Depression and Alcohol Abuse: Breaking the Cycle

depression and alcohol abuse

Introduction: The Most Common Double Diagnosis in Australia

Of all the mental health and substance use combinations that clinicians encounter in AOD treatment, the pairing of depression and alcohol use disorder is the most prevalent — and among the most clinically entrenched. According to the Australian Bureau of Statistics (ABS) National Study of Mental Health and Wellbeing, depression is the mental health condition most commonly co-occurring with alcohol use disorder among Australians. The AIHW consistently reports that people entering alcohol treatment in Australia have rates of depressive disorders substantially higher than the general population.

The two conditions do not simply co-exist. They are neurobiologically intertwined in ways that make each one actively worsen the other — creating a cycle that is genuinely difficult to interrupt without understanding its mechanics and addressing both conditions simultaneously.

This article explains that cycle: how depression drives alcohol use, how alcohol use drives depression, why the withdrawal window is particularly dangerous, and what integrated treatment looks like for someone caught between the two.

For the broader framework on how mental health conditions and addiction interact, see our pillar on why addiction happens: trauma, stress, and mental health. For more on the dual diagnosis treatment model, see dual diagnosis and addiction recovery.

The Neurobiological Connection

Depression and alcohol use disorder share overlapping neurobiological architecture — which is both why they co-occur so frequently and why treating one without the other rarely holds.

The serotonin system — Serotonin, one of the brain’s primary mood-regulating neurotransmitters, is dysregulated in major depressive disorder. Alcohol temporarily increases serotonin release — producing a short-term mood lift that gives alcohol its initial antidepressant-like quality. With chronic use, however, alcohol depletes serotonin production and reduces receptor sensitivity. The net effect over time is a serotonin system that is more impaired — and a depression that is worse — than before drinking began.

The dopamine system — Depression is characterised by reduced dopamine signalling in the brain’s reward circuits, producing anhedonia — the inability to feel pleasure from previously rewarding activities. Alcohol acutely elevates dopamine, providing temporary relief from anhedonia and producing the felt sense of reward that depression suppresses. Over time, alcohol depletes dopamine reserves and downregulates receptor sensitivity — deepening the anhedonia and making natural rewards feel even less accessible. The dependence on alcohol for any felt sense of pleasure deepens accordingly.

The HPA axis and cortisol — Both depression and alcohol use disorder involve dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis — the body’s primary stress response system. Chronically elevated cortisol is characteristic of both conditions. Alcohol initially suppresses cortisol, providing short-term stress relief — before the rebound stress response and HPA dysregulation of chronic use make the baseline anxiety and low mood of both conditions worse.

Sleep architecture — Depression disrupts sleep; alcohol disrupts sleep differently but compoundingly. Alcohol suppresses REM sleep — the stage associated with emotional processing and mood regulation — while increasing slow-wave sleep early in the night. The result is sleep that feels adequate but is neurologically non-restorative. Poor sleep worsens depression. Worsened depression drives drinking to manage the resulting low mood and insomnia. A self-reinforcing loop tightens.

How Depression Drives Alcohol Use

Depression — characterised by persistent low mood, loss of interest and pleasure, fatigue, sleep disruption, feelings of worthlessness or hopelessness, and difficulty concentrating — produces a neurobiological state in which alcohol provides genuine, short-term relief from multiple simultaneous symptoms.

The person with depression who discovers alcohol feels:

  • Mood elevation — the serotonin and dopamine activation that depression has suppressed
  • Social ease — the removal of social inhibition and self-consciousness that depression intensifies
  • Sedation — relief from the agitation, rumination, and intrusive negative thinking that characterise depressive episodes
  • Temporary anhedonia reversal — a felt sense of pleasure or relaxation at a time when very little else produces it

These are real effects — neurochemically genuine, not imagined. And for someone in the grip of depression, the relief they provide is not recreational. It is functional.

The problem is the trajectory: each of these effects is acute and short-lived, and is followed by a rebound that worsens the underlying condition. The antidepressant effect of alcohol lasts hours; the depressogenic effect of chronic use lasts weeks and months. The relief is real; the cost accumulates invisibly until it is unmistakable.

Research published in JAMA Psychiatry has found that alcohol is a central nervous system depressant that, with regular use, produces depressive symptoms even in people without prior depressive disorder — and substantially worsens them in people who already have one. People with depression who drink regularly have worse depressive outcomes, reduced treatment response to antidepressants, and significantly higher rates of suicidal ideation than those who do not.

How Alcohol Use Drives Depression

The relationship is bidirectional — but the pathway from alcohol use to depression is mechanistically direct and well-established.

Neurochemical depletion — As described above, chronic alcohol use depletes serotonin and dopamine and dysregulates the HPA axis in ways that directly produce depressive symptoms. This occurs regardless of whether depression was present before drinking began.

Sleep damage — The REM-suppressing effect of alcohol produces sleep that does not repair the emotional processing deficits that depression creates — perpetuating and deepening the depressive state through neurologically non-restorative nights.

Social withdrawal and isolation — Heavy drinking progressively narrows social life, damages relationships, and produces shame-driven withdrawal from the connections that are among the most protective factors against depression. Isolation and depression reinforce each other rapidly.

Consequence accumulation — Alcohol use disorder generates a specific set of life consequences — relationship breakdown, occupational decline, financial strain, health deterioration, legal risk — that are themselves depressogenic. The losses produced by addiction fuel the depression that drives continued drinking.

Suppression of the emotional processing that would otherwise occur — Alcohol numbs emotional experience, preventing the natural processing and integration of difficult experiences. Grief, relational pain, occupational failure, and trauma that might otherwise be worked through are instead suppressed — accumulating unprocessed, and deepening the background depressive load.

Alcohol-induced depressive episodes — The DSM-5 recognises alcohol-induced depressive disorder as a distinct diagnosis — depression that is caused directly by alcohol use and that typically resolves within weeks of abstinence. The diagnostic challenge is distinguishing alcohol-induced depression from major depressive disorder — a distinction that requires a period of abstinence to make, and that has significant implications for treatment planning.

The Withdrawal Window: The Most Dangerous Period

For people with co-occurring depression and alcohol use disorder, alcohol withdrawal creates a period of acute and substantially elevated clinical risk.

Alcohol withdrawal produces neurochemical rebound — the brain’s compensatory mechanisms, which have been working to counteract alcohol’s depressant effects, suddenly have nothing to counteract. The result is a period of neurological hyperactivation: anxiety, agitation, insomnia, elevated heart rate and blood pressure — and, for someone with underlying depression, a rapid and severe worsening of depressive symptoms.

The withdrawal-induced exacerbation of depression is one of the most clinically important and underappreciated risk periods in AOD treatment. Research consistently identifies the first weeks of alcohol withdrawal as the period of highest suicidal ideation and suicidal behaviour in this population.

This has two clinical implications:

Withdrawal requires medical supervision. For anyone with significant alcohol dependence — particularly those with a known depressive disorder — medically supervised withdrawal management is not optional. It is a safety matter. Do not attempt to stop drinking heavily and regularly without speaking to a GP first.

Psychiatric assessment during withdrawal requires clinical caution. Diagnosing major depressive disorder during acute withdrawal is unreliable — the depressive symptoms produced by withdrawal may resolve with sustained abstinence. However, psychiatric monitoring during withdrawal is essential, and any expression of suicidal ideation must be taken seriously and acted upon immediately.

If you or someone you know is expressing suicidal thoughts, contact Lifeline on 13 11 14 or call 000 immediately.

Why Treating One Without the Other Fails

The cycle described above is self-sustaining: depression drives drinking; drinking worsens depression; worsened depression drives more drinking. An intervention that addresses only one leg of this cycle leaves the other intact and operational.

When alcohol treatment is provided without treatment for depression:

  • Depressive symptoms intensify during early abstinence as alcohol is removed and the brain recalibrates
  • The person has no pharmaceutical or psychological support for the depression that has been driving their drinking
  • The felt experience of early sobriety — worse mood, poor sleep, anhedonia, hopelessness — confirms the belief that “I feel worse without alcohol” and drives relapse
  • The treatment episode is recorded as a failure; hopelessness about recovery deepens

When depression is treated without addressing alcohol use:

  • Active alcohol use impairs the neurobiological response to antidepressants (SSRIs and SNRIs are less effective in the presence of ongoing heavy drinking)
  • Alcohol continues to suppress and disrupt the emotional processing that psychological therapies for depression require
  • The depression treatment cannot stabilise because the substance driving its destabilisation remains in play

Integrated treatment — addressing both conditions simultaneously through a coordinated clinical team — is the only approach that targets the full cycle.

What Integrated Treatment Looks Like

Effective treatment for co-occurring depression and alcohol use disorder requires:

Thorough dual assessment at intake — identifying the nature and severity of both conditions, their functional relationship, which came first (where discernible), and whether the depression is likely primary, secondary, or substance-induced.

Medically managed withdrawal where required — particularly where significant physical dependence is present. For more on what this involves, see our guide on what happens during medical detox and our alcohol detox timeline.

Antidepressant consideration with appropriate timing — SSRIs and SNRIs for primary depressive disorder are generally appropriate and compatible with recovery. Where the depression appears substance-induced, a period of abstinence before introducing pharmacotherapy allows clearer assessment of what requires treatment.

CBT delivered for both conditions simultaneously — Cognitive Behavioural Therapy has strong evidence bases for both major depression and alcohol use disorder. CBT addresses the overlapping cognitive distortions — the hopelessness, the permission-giving beliefs, the catastrophising — that maintain both conditions. For more on CBT in addiction treatment, see CBT for addiction.

Behavioural activation — A specific component of CBT for depression, behavioural activation rebuilds engagement with rewarding activities to address anhedonia — and has direct relevance to addiction recovery, where rebuilding natural sources of reward and pleasure is one of the foundational tasks.

Trauma-informed care — Given the high prevalence of trauma as an underlying driver of both depression and alcohol use disorder in this population, treatment that does not address trauma is often treating the surface rather than the root. See trauma and addiction.

Intensive continuing care — The post-discharge period, when the structure of residential treatment is removed and the person re-enters their normal environment, is the highest-risk window. Daily clinical contact during this phase — as provided by HARP’s AcuteCare Plus programme — is the clinical infrastructure that bridges the gap.

HARP’s three-pronged clinical model — integrating an Addiction Specialist, Trauma Specialist Psychologist, and AOD Specialist Counsellor — is specifically designed to address the intersecting dimensions of depression and alcohol use disorder simultaneously, without departmentalising them into separate clinical streams. Read more: dual diagnosis and addiction recovery.

📞1800 534 893 | ✉ help@rehab.melbourne

Frequently Asked Questions

Does alcohol cause depression or does depression cause alcoholism? Both sequences are well-documented and clinically common. In many people, depression precedes alcohol use — alcohol is discovered as a functional, neurochemically effective relief from depressive symptoms. In others, regular heavy alcohol use produces depression through direct neurochemical depletion and HPA axis dysregulation, even in people without prior depressive disorder. The DSM-5 distinguishes between major depressive disorder (independent) and alcohol-induced depressive disorder. In practice, the relationship is often bidirectional and mutually reinforcing — making the directionality less clinically important than addressing both conditions.

Will my depression get better when I stop drinking? For many people, it does — significantly. Depressive symptoms driven primarily by alcohol’s neurochemical effects (what the DSM-5 calls alcohol-induced depressive disorder) typically resolve within weeks of sustained abstinence. However, the withdrawal period itself frequently involves an initial worsening of depressive symptoms before they improve — which is clinically important to know and to have support through. For people with a primary depressive disorder that preceded alcohol use, abstinence alone is typically not sufficient: psychological and pharmacological treatment of the depression is also required.

Can I take antidepressants if I’m in recovery from alcohol use disorder? Yes — SSRIs and SNRIs, the most commonly prescribed antidepressants in Australia, do not have significant interaction risks with sobriety and are generally appropriate for people in recovery. They are not effective in the presence of ongoing heavy drinking, which is one reason integrated treatment — addressing both conditions together — produces better outcomes than sequential treatment. A GP or psychiatrist should guide medication decisions, particularly in the post-withdrawal period.

How long does it take to feel better from co-occurring depression and alcohol use disorder? The trajectory varies. Acute withdrawal symptoms — including the worsening of depression — typically resolve within two to four weeks. Antidepressant medications generally take four to six weeks for full clinical effect. The neurochemical recalibration from chronic alcohol use — the restoration of serotonin and dopamine baseline function — takes months of sustained abstinence. Most people in integrated treatment report meaningful improvement in mood within one to three months, with continued improvement over the first year of recovery.


Sources

  1. ABS — National Study of Mental Health and Wellbeing 2020–21
  2. AIHW — Alcohol and Other Drug Treatment Services in Australia, 2022–23
  3. American Psychiatric Association — DSM-5: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (2013)
  4. Boden JM & Fergusson DM — “Alcohol and depression,” Addiction (2011) — key prospective study on the alcohol-depression relationship
  5. Saraceno L et al. — “The genetics of alcohol-related depression,” Psychiatric Genetics (2009)
  6. Alcohol and Drug Foundation (ADF) — Alcohol and Mental Health
  7. beyondblue — Alcohol, Drugs and Mental Health
  8. Lifeline Australia — 13 11 14 (crisis support, 24/7)
  9. HARP — Dual Diagnosis and Addiction Recovery
  10. National Alcohol and Other Drug Hotline — 1800 250 015 (free, confidential, 24/7)

This article is reviewed for clinical accuracy and is intended for educational purposes only. It does not constitute medical advice. If you are experiencing suicidal thoughts, call Lifeline on 13 11 14 or 000 immediately. Please consult your GP, a registered psychologist, or a qualified AOD specialist for personalised guidance.

MEET THE AUTHOR

Joshua Theodore

Intake Officer

As Head of Admissions at HARP, Josh Theodore leads the intake experience with a focus on discretion, clarity, and trust. He works closely with individuals, families, and referring professionals to ensure every client journey begins with a thorough understanding of needs, goals, and circumstances. Josh oversees the admissions process end-to-end, providing clear communication, timely coordination, and a highly personalised approach that reflects HARP’s commitment to clinical excellence and compassionate care.

In addition to client engagement, Josh manages strategic partnerships across a broad professional network, including psychologists, human resource departments, legal professionals, and other C-suite specialists. He acts as a key liaison between HARP and its referral partners, ensuring alignment, ethical integrity, and seamless collaboration. Through these relationships, Josh strengthens HARP’s multidisciplinary ecosystem, supporting integrated outcomes for clients while maintaining the highest standards of professionalism and confidentiality.

MORE ABOUT THE AUTHOR
Speak to a Specialist | No Waitlist